MFMichael A. Frölich

Michael A. Frölich

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael A. Frölich has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Quantitative Changes in Regional Cerebral Blood Flow Induced by Cold, Heat and Ischemic Pain

    by M.D. Michael A. Frölich, Hrishikesh Deshpande, Timothy Ness, Georg Deutsch

    Background: The development of arterial spin labeling methods has allowed measuring regional cerebral blood flow (rCBF) quantitatively and to show the pattern of cerebral activity associated with any state such as a sustained pain state or changes due to a neurotropic drug. Methods: The authors studied the differential effects of three pain conditions in 10 healthy subjects on a 3 Tesla scanner during resting baseline, heat, cold, and ischemic pain using continuous arterial spin labeling. Results: Cold pain showed the greatest absolute rCBF increases in left anterior cingulate cortex, left amygdala, left angular gyrus, and Brodmann area 6, and a significant rCBF decrease in the cerebellum. Changes in rCBF were characteristic of the type of pain condition: cold and heat pain showed increases, whereas the ischemic condition showed a reduction in mean absolute gray matter flow compared with rest. An association of subjects' pain tolerance and cerebral blood flow was noted. Conclusions: The observation that quantitative rCBF changes are characteristic of the pain task used and that there is a consistent rCBF change in Brodman area 6, an area responsible for the integration of a motor response to pain, should provide extremely useful information in the quest to develop an imaging biomarker of pain. Conceivably, response in BA6 may serve as an objective measure of analgesic efficacy.


  • Open Access

    What Factors Affect Intrapartum Maternal Temperature? A Prospective Cohort Study

    by Michael A. Frölich, Alice Esame, Kui Zhang, Jihua Wu, John Owen

    Background: In recent years, several reports have indicated that maternal temperature elevations during labor may also be observed in the absence of an infection. Presumed noninfectious causes of maternal temperature elevations include epidural analgesia, endogenous heat production generated by the contracting uterus, and delivery in an overheated room. To investigate the potential causes of noninfectious maternal temperature changes during labor, we conducted a prospective cohort study in women scheduled for labor induction. Methods: We recorded hourly oral temperatures from admission to delivery. We calculated whether temperature changed during labor in 81 women. We then determined if body mass index, and duration of labor, or time from rupture of amniotic sac to delivery, or oxytocin dose, would affect maternal temperature. To evaluate the possible role of epidural analgesia, we compared the temperature slope before and after starting epidural analgesia. Results: We observed an overall significant linear trend of temperature over time with an estimated temperature slope of +0.017°C/h (P = 0.0093). Patients with a positive temperature trend had also a significantly longer time from rupture of membranes to delivery (P = 0.0077) and a higher body mass index (P = 0.0067). Epidural analgesia had no effect on the temperature trend. Conclusions: In our cohort of patients, there was an overall significant linear trend of temperature over time after correcting for heterogeneity among patients. Temperature increase was associated with higher body mass index values and longer time from rupture of membranes to delivery. Epidural analgesia had no effect on maternal temperature.


  • Artifactual severe thrombocytopenia in a pregnant patient

    by Michael A. Frölich, Alan Tita, Kevin Harris

  • Oxytocin for slow progress in the first stage of spontaneous labour is not associated with different rates of caesarean or assisted delivery compared with no treatment or delayed use in second stage

    by Michael Frölich

    Bugg et al discuss the important question of whether labour augmentation with oxytocin would decrease the duration of labour. This treatment is part of active management of labour, a concept that also includes objective diagnosis of labour and early amniotomy.1 Slow progress of labour or ineffective uterine activity has been quoted as the cause of caesarean sections in 35% of women with cephalic pregnancies2 and as a possible cause for an increase in maternal and foetal morbidity.3 4 Several types of abnormal labour can be studied.

  • Hemodynamic characteristics of midazolam, propofol, and dexmedetomidine in healthy volunteers

    by Michael A. Frölich, Alireza Arabshahi, Charles Katholi, Jeevan Prasain, Stephen Barnes


  • Temporal characteristics of cold pain perception

    by Michael A. Frölich, Mark S. Bolding, Gary R. Cutter, Timothy J. Ness, Kui Zhang


  • Intravenous Lidocaine Reduces Ischemic Pain in Healthy Volunteers

    by Michael A. Frölich, Jason L. McKeown, Mark J. Worrell, Timothy J. Ness

    Background and Objectives: Lidocaine, a local anesthetic and antiarrhythmic drug that alters depolarization in neurons by blocking the fast voltage-gated sodium (Na+) channels in the cell membrane, is used for regional anesthesia, as antiarrhythmic drug, and as analgesic for various painful conditions. It is unclear whether monotherapy with intravenous lidocaine has an analgesic effect in healthy individuals. To address this important question, we studied pain perception before, during, and after the administration of intravenous lidocaine in 16 human volunteers. Our hypothesis was that lidocaine, administered as a short intravenous infusion, does not have an analgesic effect in healthy volunteers. Methods: Sixteen healthy human volunteers received systemic lidocaine at plasma concentration 2 mg/mL using a computer-assisted infusion. Participants underwent a series of sensory tests-thermal, electrical, and ischemic pain and normal pinprick sensation-at baseline, during, and 30 mins after administration of a 20-min lidocaine infusion at a 2 mg/mL effect site concentration. Results: We found a sustained decrease in ischemic pain ratings and a limited analgesic effect for electrical pain, whereas thermal pain and normal sensation did not change. Conclusions: The observed sustained analgesic effect of systemic lidocaine in the ischemic pain model suggests that lidocaine may be used to treat acute pain.


  • A single dose of fentanyl and midazolam prior to Cesarean section have no adverse neontal effects

    by Michael A.Frölich, David J. Burchfield, Tammy Euliano, Donald Caton

    Analgesia and sedation, routinely used as adjunct medications for regional anesthesia, are rarely used in the pregnant patient because of concerns about adverse neonatal effects. In an effort to obtain more information about maternal analgesia and sedation we studied neonatal and maternal effects of iv fentanyl and midazolam prior to spinal anesthesia for elective Cesarean section. In this double-blinded, randomized, placebo-controlled trial, 60 healthy women received either a combination of 1 µg·kg-1 fentanyl and 0.02 mg·kg-1 midazolam intravenously or an equal volume of iv saline at the time of their skin preparation for a bupivacaine spinal anesthetic. Sample size was based on a non-parametric power analysis (power > 0.80 and alpha = 0.05) for clinically important differences in Apgar scores. Fetal outcome measures included Apgar scores, continuous pulse oximetry for three hours, and neurobehavioural scores. Maternal outcomes included catecholamine levels, and recall of anesthesia and delivery. There were no between-group differences of neonatal outcome variables (Apgar score, neurobehavioural scores, continuous oxygen saturation). Mothers in both groups showed no difference in their ability to recall the birth of their babies. Maternal analgesia and sedation with fentanyl (1 µg·kg-1) and midazolam (0.02 mg·kg-1) immediately prior to spinal anesthesia is not associated with adverse neonatal effects. Ľanalgésie et la sédation, complément habituel à ľanesthésie régionale, sont rarement utilisées chez la femme enceinte parce qu’on craint les effets néonatals indésirables. Pour en savoir davantage sur ľanalgésie et la sédation de la mère, nous avons étudié les effets sur la mère et ľenfant du fentanyl et du midazolam iv administrés avant la rachianesthésie pour césarienne. Pour ľétude randomisée, à double insu et contrôlée contre placebo, 60 femmes en santé ont reçu une combinaison intraveineuse de 1 µg·kg-1 de fentanyl et 0,02 mg·kg-1 de midazolam ou un volume égal de solution saline iv au moment de préparer à la rachianesthésie avec bupivacaine. La taille de ľéchantillon reposait sur une analyse de puissance non paramétrique (puissance > 0,80 et alpha = 0,05) pour des différences cliniquement importantes ďindices ďApgar. Les mesures de ľévolution du fœtus comprenaient ľindice ďApgar, la sphygmo-oxymétrie continue pendant trois heures et les scores neurocomportementaux. Ľévaluation de la mère incluait les niveaux de catécholamine et la présence de souvenir de ľanesthésie et de ľaccouchement. Il n’y a pas eu de différence intergroupe des variables mesurées chez le nouveau-né (indice ďApgar, comportement neurologique, mesure continue de la saturation en oxygène). Les mères des deux groupes ont montré la même capacité à se rappeler la naissance de leurs enfants. Ľanalgésie et la sédation maternelles avec du fentanyl (1 µg·kg-1) et du midazolam (0,02 mg·kg-1) administrées immédiatement avant la rachianesthésie ne sont pas associées à des effets néonatals indésirables.